96749 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof Cyclic peptides containing at least one abnormal peptide link
Sub-classes:HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE
#2ANTIFUNGAL AGENTS AND USES THEREOF
#3PEPTIDE COMPLEX HAVING TRKB BINDING ACTIVITY
#4CD38-BINDING AGENTS AND USES THEREOF
#5CYCLOPEPTIBODIES AND USES THEREOF
#6Versatile Peptide and Protein Macrocyclization and Multimerization with Diels-Alder Cycloadditions
#7EFFICIENT CHEMO-ENZYMATIC SYNTHESIS METHOD FOR CYCLIC PEPTIDE
#8DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF
#9BICYCLIC PEPTIDYL PAN-RAS INHIBITORS
#10NOVEL COMPOUNDS FOR THE DEVELOPMENT OF REVERSIBLE COVALENT DRUGS
#11ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES
#12Peptide, Peptide Salt, Pharmaceutical Composition and Biological Tissue Calcification Inhibitor
#13HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
#14KRAS-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF MAKING AND USING
#15Anti HLA-G specific antibodies
#16ZIPPER STRUCTURE THAT HELPS THE FORMATION OF PROTEIN DIMER AND APPLICATION THEREOF
#17Versatile peptide and protein macrocyclization and multimerization with diels-alder cycloadditions
#18ANTIFUNGAL AGENTS AND USES THEREOF
#19Di-sulfide containing cell penetrating peptides and methods of making and using thereof
#20Anti HLA-G specific antibodies
#21Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#22ANTI HLA-G SPECIFIC ANTIBODIES
#23Heterotandem bicyclic peptide complexes
#24Yeats inhibitors and methods of use thereof
#25COMPOUND AND METHOD FOR PRODUCING THE SAME
#26CYCLIC PEPTIDE INHIBITORS OF HEDGEHOG PROTEINS
#27Modulation of structured polypeptide specificity
#28Anti HLA-G specific antibodies
#29KRAS-specific capture agents, compositions, and methods of making and using
#30NOVEL METHODS FOR DISPLAYING CYCLIC PEPTIDES ON BACTERIOPHAGE PARTICLES
#31Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
#32FOXP3-binding peptides and uses thereof
#33BICYCLIC PEPTIDE LIGAND PRR-A CONJUGATES AND USES THEREOF
#34Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
#35Compounds for treating cancer
#36Methods for preventing and treating pneumocystis infections
#37Anti-HIV peptides
#38Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#39Methods of treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptides
#40Heterotandem bicyclic peptide complexes
#41Peptide macrocycles against
#42Di-sulfide containing cell penetrating peptides and methods of making and using thereof
#43FoxP3-binding peptides and uses thereof
#44Mixed mode affinity chromatography carrier
#45Plexin binding regulator
#46ANTI HLA-G SPECIFIC ANTIBODIES
#47Agonist agents of CD47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death
#48Methods for preventing and treating pneumocystis infections
#49Fast dissolving pharmaceutical composition
#50Modulation of structured polypeptide specificity
#51Cyclic NTCP-targeting peptides and their uses as entry inhibitors
#52Type polypeptide targeting tumours
#53Bicyclic lipolantipeptide, preparation and use as antimicrobial agent
#54Compounds for treating cancer
#55Multivalent targeting fluorescent tracer in the near infrared range for optical imaging
#56Anti-HIV peptides
#57Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#58Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#59Methods for displaying cyclic peptides on bacteriophage particles
#60Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#61Peptidomimetic macrocycles
#62Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#63Cyclic cationic peptides with antimicrobial activity
#64Antifungal agents and uses thereof
#65Combinations with a backbone-cyclized peptide
#66Allosteric modulators of EGFR and constitutively active mutants
#67Antifungal agents and uses thereof
#68Activation of sodium potassium ATPase
#69Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
#70Proteolytically resistant hydrogen bond surrogate helices
#71Antimicrobial agent, bacterial strain, biosynthesis, and methods of use
#72Fast dissolving pharmaceutical composition
#73Peptide derivatives, preparation and uses thereof
#74Cyclic depsipeptides
#75Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
#76Antibodies that bind alpha subunit of sodium potassium ATPase
#77Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
#78Compositions and methods for producing cyclic peptoid libraries
#79Methods for preparing linked peptide rings and peptide nanotubes obtained thereby
#80Cyclic depsipeptides
#81Method for the production of cyclic molecules
#82Conformationally stabilized cell adhesion peptides
#83Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis